A 3 year PhD fellowship is available in the Group for Chromatin and Structural Biology.
The Group for Structural Biology and Chromatin (Sekulic Group) investigates chromatin biology and epigenetics with a biochemical and structural approach. The project aims at understanding changes in chromatin during mitosis and kinetochore formation. We use various biochemical and biophysical approaches (X-ray crystallography, SAXS, SANS, hydrogen-deuterium exchange …). In addition, we collaborate with cell biology groups to link structure with function.
Sekulic group is affiliated with both the Faculty of Medicine and the Department of Chemistry at the Faculty of Mathematics and Natural Sciences. The PhD student will also benefit from career development programs offered both at UiO as well as the Nordic EMBL network of the Centre for Molecular Medicine, Norway.
PhD candidate: A three-year position is available immediately. We seek highly motivated individuals with an excellent track record and experience in protein purification and biophysical and biochemical characterization of proteins and protein complexes. Experience in the field of structural biology and mass spectrometry techniques is an advantage. We offer stimulating environment with excellent working and social benefits.
The purpose of the fellowship is research training leading to the successful completion of a PhD degree.
The fellowship requires admission to the PhD program at the Faculty of Mathematics and Natural Sciences. The application to the PhD program must be submitted to the department no later than two months after taking up the position. For more information see:
The ideal candidate will have:
• A Master’s degree in biochemistry, chemistry, molecular biology or a related area
• Hands-on experience with purification of proteins and assembly of protein complexes
• Ability to independently perform experiments, analyze and interpret the results
• Excellent interpersonal/communication skills
• Excellent written and oral English
• Ability to operate as a team player in a multi-disciplinary environment
The application must include:
• Cover Letter stating motivation and research interests
• Copies of certificates and grades with explanation of the grading system
• A complete list of scientific publications
• List of references (name, relation to candidate, e-mail and telephone number)
Foreign applicants are advised to attach an explanation of their University’s grading system. Please remember that all documents should be submitted in English.
In accordance with the University of Oslo’s equal opportunities policy, we invite applications from all interested individuals regardless of gender or ethnicity.
UiO has an agreement for all employees, aiming to secure rights to research results a.o. Note that no one can be appointed for more than one specified period at the same institution.
Salary: The position will be placed as SKO 1017 (position code) with salary depending on qualifications within step 50-57 (NOK 436 900 – 490 900 per year) depending on qualifications and seniority.
About the position: Group Leader, Nikolina Sekulic (firstname.lastname@example.org).
About administrative aspects of the application: Nina Modahl (email@example.com).
Please submit your application through the web-based recruitment system https://www.jobbnorge.no/apps/jobbadmin/Project/Applicants.aspx?jobid=144835
The University of Oslo is Norway’s oldest and highest ranked educational and research institution, with 28 000 students and 7000 employees. With its broad range of academic disciplines and internationally recognised research communities, UiO is an important contributor to society.
Centre for Molecular Medicine Norway (NCMM) was established in 2008 and is the Norwegian node in the Nordic EMBL Partnership for Molecular Medicine. NCMM is a joint venture between the University of Oslo, Health Region South-East and the Research Council of Norway. From 2017 NCMM is merged with the Biotechnology Centre of Oslo and now has altogether 11 research groups. The overall objective of NCMM is to conduct cutting edge research in molecular medicine and biotechnology as well as facilitate translation of discoveries in basic medical research into clinical practice.